The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery

Digestive Surgery

Volumn 35, Issue 3, 2018, Pages 243-251

  Okamura, Yukiyasu ^a   Sugiura, Teiichi ^a   Ito, Takaaki ^a   Yamamoto, Yusuke ^a   Ashida, Ryo ^a   Uesaka, Katsuhiko ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Hepatitis B core antibody; Hepatocellular carcinoma; Non B non C hepatocellular carcinoma; Prognostic factor; Recurrence

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADULT; AGED; BLOOD; COMPLICATION; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL ANALYSIS; TUMOR RECURRENCE; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 85027731927     PISSN: 02534886     EISSN: 14219883     Source Type: Journal    
DOI: 10.1159/000479340     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, et al: Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820-826.
3. Utsunomiya T, Shimada M: Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma. Hepatol Res 2011; 41: 711-721.
4. Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, et al: Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg 2014; 259: 336-345.
5. Nagaoki Y, Hyogo H, Aikata H, Tanaka M, Naeshiro N, Nakahara T, et al: Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatol Res 2012; 42: 368-375.
6. Ohki T, Tateishi R, Goto E, Sato T, Masuzaki R, Imamura J, et al: Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors. J Viral Hepat 2010; 17: 91-97.
7. Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, et al: Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 2006; 106: 1326-1330.
8. Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, et al: Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med 2007; 146: 649-656.
9. Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, et al: Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis. A cohort study. J Viral Hepat 2009; 16: 437-443.
10. Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, Morgan TR; HALT-C Trial Group: Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology 2011; 54: 434-442.
11. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, et al: Occult hepatitis B virus infection in HVs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p52. J Med Virol 2000; 62: 151-158.
12. Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, et al: HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol 2003; 71: 492-498.
13. Nishikawa H, Osaki Y, Arimoto A, Kita R, Kimura T: Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma. Anticancer Res 2013; 33: 2211-2220.
14. Omichi K, Shindoh J, Yamamoto S, Matsuyama Y, Akamatsu N, Arita J, et al: Postoperative outcomes for patients with non-B non-C hepatocellular carcinoma: a subgroup analysis of patients with a history of hepatitis B infection. Ann Surg Oncol 2015; 22(suppl 3):1034-1040.
15. Sobin LH, Gospodarowicz MK, Wittekind CH, (eds): TNM Classification of Malignant Tumours, 7th ed. New York, Wiley-Liss, 2009.
16. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
17. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-1213.
18. Kusakabe A, Tanaka Y, Orito E, Sugauchi F, Kurbanov F, Sakamoto T, et al: A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan. J Gastroenterol 2007; 42: 298-305.
19. Wu ZF, Xu Z, Li WS, Zhang HB, Yang N, Yao XQ, et al: Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma. J Surg Res 2015; 193: 153-160.
20. Herrigel DJ, Moss RA: Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. Postgrad Med 2014; 126: 106-118.
21. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, et al: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27: 1567-1571.
22. Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, et al: A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg 2015; 261: 513-520.
23. Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y: Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma. J Cancer 2013; 4: 502-513.
24. Kaibori M, Ishizaki M, Matsui K, Kwon AH: Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy. Am J Surg 2012; 204: 300-307.
25. Yamashita Y, Imai D, Bekki Y, Kimura K, Matsumoto Y, Nakagawara H, et al: Surgical outcomes of hepatic resection for hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma. Ann Surg Oncol 2015; 22: 2279-2285.